Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Fu, Xin-Xina; b; 1 | Wei, Bina; 1 | Cao, Hai-Minga; 1 | Duan, Ruia; b | Deng, Yanga; b | Lian, Hui-Wena | Zhang, Ying-Donga; b; * | Jiang, Tenga; *
Affiliations: [a] Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, PR China | [b] Department of Neurology, Nanjing First Hospital, China Pharmaceutical University, Nanjing, Jiangsu Province, PR China
Correspondence: [*] Correspondence to: Prof. Teng Jiang, MD, PhD, and Prof. Ying-Dong Zhang, MD, PhD, Department of Neurology, Nanjing First Hospital, Nanjing Medical University, No.68 Changle Road, Nanjing, Jiangsu Province, 210006, PR China. E-mail: [email protected] (Teng Jiang) and [email protected] (Ying-Dong Zhang); ORCID: 0000-0003-4170-1156; 0000-0001-7803-5367
Note: [1] These authors contributed equally to this work.
Abstract: Background:Alzheimer’s disease (AD) is the most common type of neurodegenerative disorder. There are few effective medications for halting the progression of AD. Telmisartan (TEL) is a widely used anti-hypertensive drug approved by FDA. Aside from treating hypertension, TEL has been revealed to provide protection against AD. However, the underlying mechanisms remain unclear. Objective:To investigate the mechanisms underlying the beneficial effects of TEL against AD. Methods:Eight-month-old APP/PS1 mice were administered with 5 mg/kg TEL once per day for 4 successive months. Nesting test, Y-maze test, and Morris water maze test were employed to assess the cognitive and executive functions. Neuronal and synaptic markers, amyloid-β (Aβ) pathology, neuroinflammation, and oxidative stress in the brains were measured. Specifically, components involved in Aβ production and degradation pathway were analyzed to explore the mechanisms underlying the therapeutic effect of TEL against Aβ pathology. The primary microglia were used to uncover the mechanisms underlying the anti-inflammatory effects of TEL in AD. Additionally, the preventive effect of TEL against AD were investigated using 4-month-old APP/PS1 mice. Results:TEL treatment ameliorated cognitive and executive impairments, neuronal and synaptic injury, Aβ pathology, neuroinflammation, and oxidative stress in APP/PS1 mice. The favorable effects of TEL on Aβ pathology were achieved by inhibiting enzymatic Aβ production and facilitating enzymatic and autophagic Aβ degradation. Meanwhile, the anti-inflammatory effects of TEL were accomplished via microglial PPARγ/NLRP3 pathway. The administration of TEL prior to symptom onset prevented AD-related cognitive decline and neuropathologies. Conclusion:TEL represents a promising agent for AD prevention and treatment.
Keywords: Alzheimer’s disease, amyloid-β pathology, autophagy, cognitive and executive impairments, neuroinflammation, neuronal and synaptic injury, NLRP3, oxidative stress, PPARγ , telmisartan
DOI: 10.3233/JAD-230133
Journal: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 919-933, 2023
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]